Apr 25, 2025

Laurus Labs is shifting from generics to high-margin CDMO. New FDF capacity, fermentation bets, and improved ROCE signal a strong multi-year growth cycle.

3 Comments

KETAN

Apr 28, 2025

very well & crisply crafted the message.

Thanks Ketan

Thanks for this detailed review

Laurus has best in class management so demanding high premium. It’s a long term game

Reply

Share

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

MoneyMuscle

Laurus Labs Q4 FY25 Results: Profit Up 122…